Jacqueline M Barkoski1, Claire Philippat2, Daniel Tancredi3, Rebecca J Schmidt4, Sally Ozonoff5, Dana Boyd Barr6, William Elms7, Deborah H Bennett7, Irva Hertz-Picciotto4. 1. Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA. Electronic address: jmbarkoski@ucdavis.edu. 2. University Grenoble Alpes, Inserm, CNRS, Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, Institute for Advanced Biosciences (IAB), Grenoble, France. 3. Department of Pediatrics, School of Medicine, University of California, Davis, CA, USA. 4. Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA; MIND (Medical Investigations of Neurodevelopmental Disorders) Institute, University of California, Davis, CA, USA. 5. MIND (Medical Investigations of Neurodevelopmental Disorders) Institute, University of California, Davis, CA, USA; Department of Psychiatry and Behavioral Sciences, School of Medicine, University of California, Davis, CA, USA. 6. Rollins School of Public Health, Emory University, Atlanta, GA, USA. 7. Department of Public Health Sciences, School of Medicine, University of California, Davis, CA, USA.
Abstract
BACKGROUND: We assessed the relationships between prenatal pyrethroid pesticide exposure and autism spectrum disorders (ASD) or non-typical development (non-TD) at 3 years. METHODS: Participants were mother-child pairs (n = 201) in the MARBLES (Markers of Autism Risk in Babies-Learning Early Signs) cohort. Because familial recurrence risk is high, MARBLES enrolls pregnant women with a family history of ASD. Children from these pregnancies were clinically assessed at 3 years of age and classified into 3 outcome categories: ASD, typically developing (TD), or non-TD (neither TD or ASD). Repeated maternal second and third trimester urine samples were analyzed for pyrethroid metabolite 3-phenoxybenzoic acid (3-PBA). Multinomial logistic regression was used to obtain relative risk ratios (RRR) linking 3-PBA concentrations averaged across each trimester and over pregnancy with child's outcome: ASD or non-TD vs. TD. Models were adjusted for specific gravity, maternal pre-pregnancy BMI, prenatal vitamin use, birth year, home-ownership, and pregnancy concentrations of TCPy (3,5,6-trichloro-2-pyridinol, a metabolite of chlorpyrifos). RESULTS: The median specific gravity corrected 3-PBA concentration of all samples was 1.46 ng/mL. Greater second trimester 3-PBA concentrations were associated with a relative risk ratio (RRR) for ASD of (RRR: 1.50 (95% CI 0.89 to 2.51), p = 0.12). There were no differences between non-TD and TD. CONCLUSIONS: This study found no evidence for differences in 3-PBA comparing non-TD with TD. A modestly elevated RRR was found comparing second trimester urinary 3-PBA concentrations for ASD versus TD; however, the confidence interval was wide and hence, these findings cannot be considered definitive.
BACKGROUND: We assessed the relationships between prenatal pyrethroid pesticide exposure and autism spectrum disorders (ASD) or non-typical development (non-TD) at 3 years. METHODS: Participants were mother-child pairs (n = 201) in the MARBLES (Markers of Autism Risk in Babies-Learning Early Signs) cohort. Because familial recurrence risk is high, MARBLES enrolls pregnant women with a family history of ASD. Children from these pregnancies were clinically assessed at 3 years of age and classified into 3 outcome categories: ASD, typically developing (TD), or non-TD (neither TD or ASD). Repeated maternal second and third trimester urine samples were analyzed for pyrethroid metabolite 3-phenoxybenzoic acid (3-PBA). Multinomial logistic regression was used to obtain relative risk ratios (RRR) linking 3-PBA concentrations averaged across each trimester and over pregnancy with child's outcome: ASD or non-TD vs. TD. Models were adjusted for specific gravity, maternal pre-pregnancy BMI, prenatal vitamin use, birth year, home-ownership, and pregnancy concentrations of TCPy (3,5,6-trichloro-2-pyridinol, a metabolite of chlorpyrifos). RESULTS: The median specific gravity corrected 3-PBA concentration of all samples was 1.46 ng/mL. Greater second trimester 3-PBA concentrations were associated with a relative risk ratio (RRR) for ASD of (RRR: 1.50 (95% CI 0.89 to 2.51), p = 0.12). There were no differences between non-TD and TD. CONCLUSIONS: This study found no evidence for differences in 3-PBA comparing non-TD with TD. A modestly elevated RRR was found comparing second trimester urinary 3-PBA concentrations for ASD versus TD; however, the confidence interval was wide and hence, these findings cannot be considered definitive.
Authors: Katarzyna Chawarska; Frederick Shic; Suzanne Macari; Daniel J Campbell; Jessica Brian; Rebecca Landa; Ted Hutman; Charles A Nelson; Sally Ozonoff; Helen Tager-Flusberg; Gregory S Young; Lonnie Zwaigenbaum; Ira L Cohen; Tony Charman; Daniel S Messinger; Ami Klin; Scott Johnson; Susan Bryson Journal: J Am Acad Child Adolesc Psychiatry Date: 2014-10-02 Impact factor: 8.829
Authors: Chunyan Yang; Weiwei Zhao; Kui Deng; Vanessa Zhou; Xiaohua Zhou; Yan Hou Journal: Environ Sci Pollut Res Int Date: 2017-05-24 Impact factor: 4.223
Authors: Jacqueline Barkoski; Deborah Bennett; Daniel Tancredi; Dana Boyd Barr; William Elms; Irva Hertz-Picciotto Journal: Environ Res Date: 2018-06-01 Impact factor: 6.498
Authors: Trent Gaugler; Lambertus Klei; Stephan J Sanders; Corneliu A Bodea; Arthur P Goldberg; Ann B Lee; Milind Mahajan; Dina Manaa; Yudi Pawitan; Jennifer Reichert; Stephan Ripke; Sven Sandin; Pamela Sklar; Oscar Svantesson; Abraham Reichenberg; Christina M Hultman; Bernie Devlin; Kathryn Roeder; Joseph D Buxbaum Journal: Nat Genet Date: 2014-07-20 Impact factor: 38.330
Authors: Robert B Gunier; Asa Bradman; Kim G Harley; Katherine Kogut; Brenda Eskenazi Journal: Environ Health Perspect Date: 2017-05-25 Impact factor: 9.031
Authors: Astrid N Zamora; Deborah J Watkins; Karen E Peterson; Martha M Téllez-Rojo; Howard Hu; John D Meeker; Alejandra Cantoral; Adriana Mercado-García; Erica C Jansen Journal: Environ Res Date: 2021-08-29 Impact factor: 6.498
Authors: Deborah H Bennett; Stefanie A Busgang; Kurunthachalam Kannan; Patrick J Parsons; Mari Takazawa; Christopher D Palmer; Rebecca J Schmidt; John T Doucette; Julie B Schweitzer; Chris Gennings; Irva Hertz-Picciotto Journal: Environ Int Date: 2022-01-24 Impact factor: 13.352
Authors: Emily E Joyce; Jorge E Chavarro; Juliette Rando; Ashley Y Song; Lisa A Croen; M Daniele Fallin; Irva Hertz-Picciotto; Rebecca J Schmidt; Heather Volk; Craig J Newschaffer; Kristen Lyall Journal: Autism Res Date: 2022-03-08 Impact factor: 4.633